Dekker Martin 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 17, 2018
Insider Transaction Report
Form 4
Dekker Martin
VP of Device Engineering
Transactions
- Award
Common Stock
2018-01-12+21,675→ 76,983 total - Award
Stock Option (right to buy)
2018-01-12+80,000→ 80,000 totalExercise: $2.03Exp: 2028-01-12→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.